EUVIMEDEUVIMED entdecken
Crossref

The effect of SGLT2 inhibition on immune cells and transplant rejection/failure: A drug-targeted mendelian randomization study

Hanyu Xiao, Xiang Zeng, Qidan Pang, Hong Chen, Suhe Lai

Transplant Immunology · 2026-06 · 96 · 102385

DOI: 10.1016/j.trim.2026.102385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2026-06. Verfasst von Hanyu Xiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery/Gastrointestinal Surgery, Bishan Hospital of Chongqing Medical University, Bishan Hospital of Chongqing, Chongqing, Chi…. Hauptthemen laut MEDLINE: Graft Rejection, Sodium-Glucose Transporter 2 Inhibitors, Organ Transplantation, Sodium-Glucose Transporter 2. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Sodium-glucose cotransporter-2 inhibitors (SGLT2i) yield additional cardiorenal benefits beyond glycemic control. Emerging evidence suggests that SGLT2i have potential benefits in organ transplantation, though causal relationships remain unclear. This study aimed to investigate the causal effect of SGLT2 inhibition on transplant rejection and failure (TRF) and the mediating role of immune cell profiles. METHODS A drug-targeted and mediation mendelian randomization (MR) study was conducted. Genetic instruments for SGLT2 inhibition were constructed using variants associated with SLC5A2 expression and HbA1c reduction. Data on 731 immune cell traits came from a Sardinian cohort (n = 3757), and TRF data were sourced from the FinnGen consortium (289 cases, 392134 controls). The causal effects of SGLT2 inhibition on TRF and immune cells were estimated, followed by a mediation analysis to identify immune mediators. RESULTS Genetically proxied SGLT2i was associated with a reduced risk of TRF (OR = 0.81 per 0.66% HbA1c reduction, 95% CI: 0.70-0.93, P = 0.003). SGLT2i have a significant impact on 66 immune cell traits, including increasing naive B cells and Tregs while decreasing effector memory T cells, CD8 + NK cells and specific myeloid activation markers. Among these, a higher level of CD25hi CD45RA- CD4+ non-Treg cells was associated with increased TRF risk, but the mediation analysis failed to reach statistical significance (mediation effect: 5.86%; 95% CI: -0.63% to 12.35%; P = 0.076). CONCLUSION This MR study offers genetic evidence supporting SGLT2 inhibition's protective effect against TRF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionSodium-Glucose Transporter 2 InhibitorsOrgan TransplantationSodium-Glucose Transporter 2T-Lymphocytes, RegulatoryHumansMendelian Randomization AnalysisGlycated HemoglobinPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Allograft failureImmune cellMendelian randomizationSGLT2 inhibitorTransplant rejectionTransplantation

Substanzen

Sodium-Glucose Transporter 2 InhibitorsSodium-Glucose Transporter 2SLC5A2 protein, humanGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of General Surgery/Gastrointestinal Surgery, Bishan Hospital of Chongqing Medical University, Bishan Hospital of Chongqing, Chongqing, China.
  • Department of Nephrology, Bishan Hospital of Chongqing Medical University, Bishan Hospital of Chongqing, Chongqing, China.
  • Department of General Surgery/Gastrointestinal Surgery, Bishan Hospital of Chongqing Medical University, Bishan Hospital of Chongqing, Chongqing, China. Electronic address: bschenh@163.com.
  • Department of General Surgery/Gastrointestinal Surgery, Bishan Hospital of Chongqing Medical University, Bishan Hospital of Chongqing, Chongqing, China. Electronic address: 271640125@qq.com.

Zitieren

APA

Xiao, H., Zeng, X., Pang, Q., Chen, H., & Lai, S. (2026). The effect of SGLT2 inhibition on immune cells and transplant rejection/failure: A drug-targeted mendelian randomization study. Transplant Immunology, 96, 102385. https://doi.org/10.1016/j.trim.2026.102385

Vancouver

Xiao H, Zeng X, Pang Q, Chen H, Lai S. The effect of SGLT2 inhibition on immune cells and transplant rejection/failure: A drug-targeted mendelian randomization study. Transplant Immunology. 2026;96:102385. doi:10.1016/j.trim.2026.102385

BibTeX
@article{Xiao2026,
  author = {Xiao, Hanyu and Zeng, Xiang and Pang, Qidan and Chen, Hong and Lai, Suhe},
  title = {The effect of SGLT2 inhibition on immune cells and transplant rejection/failure: A drug-targeted mendelian randomization study},
  journal = {Transplant Immunology},
  year = {2026},
  volume = {96},
  pages = {102385},
  doi = {10.1016/j.trim.2026.102385}
}
Kostenlos starten →